Endovascular aneurysm repair requires precise imaging before and after surgery. Standard computed tomography angiography delivers substantial intravenous contrast volumes, which threaten vulnerable nephrons. Clinicians now evaluate innovative techniques to mitigate nephrotoxicity. Recent evidence indicates that transarterial CTA offers an effective alternative for high-risk individuals, protecting baseline renal filtration while preserving indispensable cross-sectional diagnostic anatomy.

The Clinical Challenge of Renal Impairment in EVAR

Endovascular aortic repair represents the preferred treatment for both abdominal and thoracoabdominal aortic aneurysms. However, successful device selection and lifelong surveillance demand repeated contrast imaging. Standard intravenous protocols administer between eighty and one hundred twenty milliliters of iodinated contrast agent. Consequently, patients with chronic kidney disease face severe risks of contrast-induced acute kidney injury. This renal deterioration accelerates progression to dialysis, prolongs hospital stays, and increases long-term cardiovascular mortality.

Furthermore, vascular surgeons frequently manage complex aortic anatomy in elderly patients with hypertension and diabetic nephropathy. Because standard intravenous administration dilutes contrast throughout the cardiopulmonary circulation, operators require high volumes to achieve adequate arterial brightness. Therefore, surgical teams urgently need ultra-low-dose imaging techniques that preserve diagnostic quality without precipitating renal failure. Although carbon dioxide angiography and non-contrast magnetic resonance imaging exist, they often fail to delineate critical branch vessel details accurately. As a result, direct aortic contrast administration provides a targeted solution that safeguards failing kidneys.

Technical Execution of Transarterial CTA

The transarterial technique utilizes transbrachial catheterization to introduce contrast directly into the aorta. Radiologists insert a small 4-French or 5-French catheter through the brachial artery under local anesthesia and ultrasound guidance. Subsequently, the operator advances the catheter tip into the descending thoracic aorta immediately above the aneurysm. By positioning the catheter directly above the target zone, the team injects contrast into the central arterial stream. Consequently, the contrast agent avoids systemic cardiopulmonary dilution.

Therefore, radiologists obtain robust arterial opacification using only a fraction of conventional contrast doses. Interventionalists synchronize mechanical power injection with multidetector CT acquisition to capture the peak arterial phase. In addition, the transbrachial approach provides smooth downhill access into the thoracoabdominal aorta, bypassing tortuous iliac arteries. Furthermore, direct aortic injection enables selective visualization of vital visceral branches, including the celiac axis, superior mesenteric artery, and renal arteries. Thus, surgical teams evaluate sealing zones and identify prospective endoleaks with total clarity.

Renal Outcomes and Prevention of Kidney Injury

A recent clinical investigation by Beropoulis and colleagues evaluated 216 patients with chronic kidney disease undergoing this transbrachial protocol. The study analyzed 84 thoracoabdominal and 106 abdominal aortic aneurysm cases. The authors compared these individuals against a control cohort of 45 patients with normal renal function receiving standard intravenous CTA. Notably, the primary endpoint measured freedom from contrast-induced acute kidney injury.

Remarkably, the catheter group demonstrated outstanding renal preservation across all clinical metrics. The transarterial protocol required an average contrast volume of only 31.70 milliliters, reflecting a massive reduction compared to intravenous controls. Consequently, the intervention group experienced an average serum creatinine reduction of 0.11 milligrams per deciliter. Furthermore, their mean glomerular filtration rate improved by 2.13 percent following the examination. None of the chronic kidney disease patients required emergency renal replacement therapy. Therefore, this targeted contrast protocol completely eliminated contrast-induced acute kidney injury in a highly vulnerable cohort.

Diagnostic Accuracy and Vessel Attenuation

Renal protection cannot compromise diagnostic image clarity. Fortunately, the clinical trial proved that transarterial CTA produces exceptional diagnostic image quality. Investigators measured luminal enhancement in Hounsfield units and calculated contrast-to-noise ratios across multiple arterial stations. Moreover, two independent radiologists validated these findings using intraclass correlation coefficients.

Specifically, the transarterial scans achieved mean attenuation values between 210.4 and 241.4 Hounsfield units. Although control scans with standard intravenous contrast reached over 300 Hounsfield units, transarterial values comfortably exceeded the diagnostic threshold of 200 Hounsfield units. In addition, contrast-to-noise ratios ranged reliably between 9.1 and 11.1 across all evaluated aortic regions. Intraclass correlation coefficients between independent observers reached 0.987 to 0.992, confirming superb diagnostic agreement. Radiologists identified key landing zones, vital branch arteries, and post-repair endoleaks without difficulty. Thus, direct transarterial injection preserves diagnostic confidence while conserving renal health.

Procedural Safety and Clinical Implications

Clinicians must evaluate puncture-site safety when selecting an arterial intervention. The trial evaluated secondary safety endpoints, including access complications and cerebrovascular incidents. Because operators puncture the brachial artery, medical teams monitored patients carefully for local hematomas, pseudoaneurysms, and distal limb ischemia.

Overall, the protocol demonstrated a favorable safety profile. False aneurysms developed in ten patients, representing 4.6 percent of the cohort, while two patients experienced small hematomas. Furthermore, two patients suffered transient cerebrovascular events that resolved completely without persistent neurological deficits. No patient suffered permanent vascular injury or death. Interventionalists can further reduce local access complications by using routine ultrasound guidance, low-profile sheaths, and systematic manual or mechanical compression. Therefore, the significant nephroprotective benefit far outweighs the modest risk of access morbidity. In clinical practice, this method provides an invaluable diagnostic pathway for patients facing complex aortic repair.

Frequently Asked Questions

Why is transarterial CTA preferred over standard intravenous CTA in CKD patients?

Standard intravenous CTA requires large contrast doses because the agent dilutes across the cardiopulmonary circulation before reaching the aorta. In contrast, transarterial CTA injects low contrast volumes directly into the aortic lumen through a dedicated catheter. This targeted delivery significantly reduces total systemic contrast exposure while maintaining excellent luminal attenuation. Consequently, the technique prevents contrast-induced acute kidney injury, making it ideal for patients with impaired baseline renal function.

What access route is typically used for transarterial CTA during EVAR evaluation?

Interventional teams typically utilize the transbrachial arterial route for catheter placement. Operators introduce a 4-French or 5-French catheter through the brachial artery into the descending thoracic aorta. This approach provides straightforward anatomical alignment into the thoracoabdominal aorta without disturbing femoral access sites reserved for endovascular stent-grafts. Furthermore, direct fluoroscopic guidance and ultrasound-assisted arterial puncture ensure secure catheter placement while minimizing local vascular access complications during the diagnostic evaluation.

Does reducing the contrast dose in transarterial CTA compromise image quality?

No, reducing the contrast dose does not compromise diagnostic accuracy. Because the catheter delivers concentrated contrast medium directly into the aorta, attenuation values consistently range above 200 Hounsfield units. These values easily surpass the diagnostic threshold required to assess vessel diameter, identify endoleaks, and map branch anatomy. Clinical studies confirm excellent contrast-to-noise ratios and inter-reader reproducibility, proving that lower contrast volumes still deliver superior image clarity.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Beropoulis E et al. Transarterial Computed Tomographic Angiography in Patients With Impaired Renal Function Undergoing Endovascular Aortic Repair. Vasc Endovascular Surg. 2026 Oct 20. doi: 10.1177/15385744261501882. PMID: 42902594.
2. van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, risk factors, imaging features and risk reduction strategies. Eur Radiol. 2018;28(7):2845-2855.
3. Wanhainen A, Verzini F, Van Herzeele I, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2019;57(1):8-93.